Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany

Open Access

Peer-reviewed

Research Article

Emma Sullivan,

Affiliation Adelphi Real World, Manchester, United Kingdom
⨯
James Piercy,

Affiliation Adelphi Real World, Manchester, United Kingdom
⨯
John Waller,

Affiliation Adelphi Real World, Manchester, United Kingdom

http://orcid.org/0000-0002-7322-991X

⨯
Christopher M. Black,

Affiliation Merck & Co., Inc., Kenilworth, NJ, United States of America
⨯
Sumesh Kachroo

* E-mail: sumesh.kachroo@merck.com

Affiliation Merck & Co., Inc., Kenilworth, NJ, United States of America
⨯

Reader Comments (0)

Ulcerative colitis
Is the Subject Area "Ulcerative colitis" applicable to this article?

Thanks for your feedback.
Patients
Is the Subject Area "Patients" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Psychological attitudes
Is the Subject Area "Psychological attitudes" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Crohn's disease
Is the Subject Area "Crohn's disease" applicable to this article?

Thanks for your feedback.
Europe
Is the Subject Area "Europe" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.